Associate Professor of Clinical Medicine and Director of the Breast Cancer Research Program
Dr. Vahdat's research is focused on many aspects of the care of patients with breast cancer and reflects the goals of the WMC Breast Cancer Research Program. The goals of the Program are to understand the biology of the disease- with a focus on metastases, to provide access to new agents to treat our patients and to understand why certain side effects occur with certain drugs with a long term view to prevention or identification of patients at high risk for development of these effects. As such, the research portfoliio reflects these broad-based concepts. The breast cancer research group has available a wide variety of active new agents for breast cancer in early phase II to III trials. We have several trials in place that are looking to change the paradigm of high risk for recurrence breast cancer (Phase II trial of tetrathiomolybdate in breast cancer at high risk of recurrence) and collaboration with world-class laboratory scientists at WMC to help understand these processes.